Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 14 December 2017

 
 
 
   

News

 

14122017 The associations representing the European and British life science industry have...
14 December 2017

Organisations representing the life science industry in the EU and the UK have called for medicines to be a priority... Read more

 
 
 
   

Blogs

 

13122017 A relentless commitment to the blame game
13 December 2017 - Nathalie Moll

To really address the significant challenges faced by our healthcare systems and our society will require new levels... Read more

13122017 Drugs incentives have saved lives in Europe (Guest blog)
12 December 2017

Without strong incentives to spur continued investment in medical innovation, we cannot hope to ensure the sustainability... Read more

 
 
 
   

Events

 

06122017 4th European Conference on Clinical Research
26 February 2018 (Vienna, Austria)

A EUCROF conference Read more

13122017 European Conference on Rare Diseases and Orphan Products
10 May 2018 (Messe Wien Congress Center, Vienna, Austria)

The largest multi-stakeholder gathering in Europe for the rare disease community Read more

 
 
 
   

What we are reading

 
Access to clinical trials and innovative treatments at risk after Brexit
On 14 December 2017 (EurActiv)

Patients in Britain risk delays to access life-saving medicines if the UK deviates from EU regulatory standards post-Brexit,... Read more

Haemophilia A trial results 'mind-blowing'
On 14 December 2017 (BBC)

British doctors say they have achieved "mind-blowing" results in an attempt to rid people of haemophilia A Read more

Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped
On 07 December 2017 (EurActiv)

Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive... Read more